Mednet Logo

When would you use rusfertide to treat polycythemia vera?

Community PollStarted

When will you use rusfertide to treat polycythemia vera?

7 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Hematology · Medical University of South Carolina
Answered on

This is an interesting question, as the FDA only approved rusfertide (Mimrylo) just a few days ago based on the results of the VERIFY trial- a double-blind, placebo-controlled RCT (n=293). Patients were allowed to continue standard-of-care therapy; about 40% of patients continued hydroxyurea, but a ...

Join for free or sign in to see the full answer